Please upgrade your browser.
An attorney from the UK who handles patient medical appeals and a physician from the M. D. Anderson Cancer Center think that the so-called Comparative Effectiveness scheme tucked by Congress into the stimulus package is merely the camel's nose in the tent. Read this New York Times blog post.
Merck & Co. agreed to buy rival Schering-Plough Corp. in a $41.1 billion deal that furthers consolidation by the ailing drug industry to form more diversified companies.
Thousands of patients with terminal cancer were dealt a blow last night after a decision was made to deny them life prolonging drugs.
Roche Holding increased its takeover bid for Genentech to $45.7 billion, giving shareholders until March 20 to decide. The latest bid, which was made after last week's meeting between Roche and Genentech.
On February 23rd, 2009, Illinois Governor Pat Quinn signed a Proclamation that designated the month of March, 2009, as Kidney Cancer Awareness Month. The Kidney Cancer Association thanks Linda Cox, mother of the late Lori Ann Shew, who died from kidney cancer in 2005.
The discovery could lead to tests that would identify kidney cancer at an early stage, improving treatment outcomes for patients.
The reality is that from Canada to Cuba socialized health care's record is appalling. It's impossible to tally how many patients die waiting for routine preventative procedures or how many innovations go undiscovered because precious resources are squandered.
The drug, which is given by mouth, is designed for patients with advanced or metastatic kidney cancer.
The son of the late broadcaster Tony Wilson is calling for a change in the NHS system which leaves dying patients fighting for drugs to keep themselves alive.
"This model can be used to stratify patients on clinical trials and in clinical practice," said Dr. Heng.
|Powered by NeonCRM|